These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 9839618)
1. Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors. St Croix B; Man S; Kerbel RS Cancer Lett; 1998 Sep; 131(1):35-44. PubMed ID: 9839618 [TBL] [Abstract][Full Text] [Related]
2. Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells. Croix BS; Rak JW; Kapitain S; Sheehan C; Graham CH; Kerbel RS J Natl Cancer Inst; 1996 Sep; 88(18):1285-96. PubMed ID: 8797768 [TBL] [Abstract][Full Text] [Related]
3. Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Kerbel RS; St Croix B; Florenes VA; Rak J Hum Cell; 1996 Dec; 9(4):257-64. PubMed ID: 9183656 [TBL] [Abstract][Full Text] [Related]
4. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Frankel A; Man S; Elliott P; Adams J; Kerbel RS Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766 [TBL] [Abstract][Full Text] [Related]
5. Cremophor EL reversed multidrug resistance in vitro but not in tumor-bearing mouse models. Watanabe T; Nakayama Y; Naito M; Oh-hara T; Itoh Y; Tsuruo T Anticancer Drugs; 1996 Nov; 7(8):825-32. PubMed ID: 8991185 [TBL] [Abstract][Full Text] [Related]
6. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Frankel A; Buckman R; Kerbel RS Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815 [TBL] [Abstract][Full Text] [Related]
7. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. Graham CH; Kobayashi H; Stankiewicz KS; Man S; Kapitain SJ; Kerbel RS J Natl Cancer Inst; 1994 Jul; 86(13):975-82. PubMed ID: 8007019 [TBL] [Abstract][Full Text] [Related]
8. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells. Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311 [TBL] [Abstract][Full Text] [Related]
9. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. Wartenberg M; Frey C; Diedershagen H; Ritgen J; Hescheler J; Sauer H Int J Cancer; 1998 Mar; 75(6):855-63. PubMed ID: 9506530 [TBL] [Abstract][Full Text] [Related]
10. Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models. Watanabe T; Naito M; Oh-hara T; Itoh Y; Cohen D; Tsuruo T Jpn J Cancer Res; 1996 Feb; 87(2):184-93. PubMed ID: 8609068 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy. Walker J; Martin C; Callaghan R Eur J Cancer; 2004 Mar; 40(4):594-605. PubMed ID: 14962729 [TBL] [Abstract][Full Text] [Related]
12. The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833. Ehrlich PH; Moustafa ZA; Archinal-Mattheis AE; Newman MJ; Bair KW; Cohen D Anticancer Res; 1997; 17(1A):129-33. PubMed ID: 9066642 [TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents. Francia G; Man S; Teicher B; Grasso L; Kerbel RS Mol Cell Biol; 2004 Aug; 24(15):6837-49. PubMed ID: 15254249 [TBL] [Abstract][Full Text] [Related]
14. Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids. Wartenberg M; Fischer K; Hescheler J; Sauer H Int J Cancer; 2000 Jan; 85(2):267-74. PubMed ID: 10629088 [TBL] [Abstract][Full Text] [Related]
15. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines. Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443 [TBL] [Abstract][Full Text] [Related]
16. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody. Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396 [TBL] [Abstract][Full Text] [Related]
17. Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy. Xing H; Wang S; Hu K; Tao W; Li J; Gao Q; Yang X; Weng D; Lu Y; Ma D J Cancer Res Clin Oncol; 2005 Aug; 131(8):511-9. PubMed ID: 15924242 [TBL] [Abstract][Full Text] [Related]
18. Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro. Green SK; Francia G; Isidoro C; Kerbel RS Mol Cancer Ther; 2004 Feb; 3(2):149-59. PubMed ID: 14985455 [TBL] [Abstract][Full Text] [Related]
19. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors. Krishna R; Mayer LD Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743 [TBL] [Abstract][Full Text] [Related]
20. The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers. Tunggal JK; Melo T; Ballinger JR; Tannock IF Int J Cancer; 2000 Apr; 86(1):101-7. PubMed ID: 10728602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]